Cytovia Therapeutics, Inc appoints Dr. Wei Li as Chief Scientific Officer to accelerate the development of iPSC CAR-NK Cell Therapy for Cancer


You May Also Like

Myriad Acquires Sividon Diagnostics

SALT LAKE CITY, May 31, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

Physeon’s Veinplicity Device Featured on ABC Affiliate KSTP Channel 5

“VIVA” Trial Enrolling at Mayo ClinicSCHAFFHAUSEN, Switzerland, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Physeon ...